Effect of preoperatively administered oxycontin and intraoperative nitrous oxide use on remifentanil-induced analgesia - ND
- Conditions
- postoperative painMedDRA version: 9.1Level: LLTClassification code 10064882Term: Procedural pain
- Registration Number
- EUCTR2008-005808-72-IT
- Lead Sponsor
- POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- Not specified
age between 18 and 70 years, ASA (American Society of Anaesthesiologists) I-II, elective laparoscopic cholecistectomy
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
patients refusal, BMI (Body Mass Index)> 30 Kg/m2, pregnant women, patients with a history of drug or alcohol abuse, patients taking analgesics drugs, steroids, drugs acting at NMDA receptors, antiemetics and MAO inhibitors, patients with nausea and vomiting within 24 hours before anaesthesia or pre-existing chronic pain disorder or chronic inflammatory disease or psychiatric disorder or any contraindications to the self-administration of opioids (i.e. inability to understand PCA (patient controlled analgesia).
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: The primary aim of the study is to investigate if oxycontin administered before general anaesthesia may be effective for the prevention of hyperalgesia as nitrous oxide and if the oxycontin-nitrous oxide combination may enhance single (oxycontin or nitrous oxide) therapy efficacy in patients undergoing laparoscopic cholecistectomy.;Secondary Objective: nd;Primary end point(s): VAS (visual analogue score) at rest and after coughing, postoperative tramadol consumption administered by PCA (patient controlled analgesia).
- Secondary Outcome Measures
Name Time Method